In last trading session, Enveric Biosciences Inc (NASDAQ:ENVB) saw 0.38 million shares changing hands with its beta currently measuring 0.83. Company’s recent per share price level of $1.01 trading at $0.1 or 10.95% at ring of the bell on the day assigns it a market valuation of $7.36M. That closing price of ENVB’s stock is at a discount of -591.09% from its 52-week high price of $6.98 and is indicating a premium of 35.64% from its 52-week low price of $0.65. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.37 million shares which gives us an average trading volume of 4.43 million if we extend that period to 3-months.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Upright in the green during last session for gaining 10.95%, in the last five days ENVB remained trading in the green while hitting it’s week-highest on Friday, 04/12/24 when the stock touched $1.01 price level, adding 1.94% to its value on the day. Enveric Biosciences Inc’s shares saw a change of -22.31% in year-to-date performance and have moved 8.60% in past 5-day. Enveric Biosciences Inc (NASDAQ:ENVB) showed a performance of -12.93% in past 30-days. Number of shares sold short was 0.25 million shares which calculate 0.02 days to cover the short interests.
Enveric Biosciences Inc (ENVB) estimates and forecasts
Statistics highlight that Enveric Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -50.97% of value to its shares in past 6 months, showing an annual growth rate of 75.28% while that of industry is 13.30. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 68.80% in the current quarter and calculating 82.60% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 71.22% during past 5 years.
ENVB Dividends
Enveric Biosciences Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Insiders are in possession of 7.06% of company’s total shares while institution are holding 6.71 percent of that, with stock having share float percentage of 7.22%. Investors also watch the number of corporate investors in a company very closely, which is 6.71% institutions for Enveric Biosciences Inc that are currently holding shares of the company. AdvisorShares Investments, LLC is the top institutional holder at ENVB for having 0.1 million shares of worth $0.34 million. And as of Jun 29, 2023, it was holding 4.60% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 29578.0 shares on Jun 29, 2023. The number of shares represents firm’s hold over 1.36% of outstanding shares, having a total worth of $99677.0.
On the other hand, AdvisorShares Trust-AdvisorShares Psychedelics ETF and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 29, 2023, the former fund manager was holding 0.15 million shares of worth $0.35 million or 6.73% of the total outstanding shares. The later fund manager was in possession of 12515.0 shares on Jun 29, 2023, making its stake of worth around $42175.0 in the company or a holder of 0.57% of company’s stock.
